CTNM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Contineum Therapeutics, Inc. Class A Common Stock

NASDAQ | CTNM

12.44

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$333.00M

Market Cap

-

P/E Ratio

-2.07

EPS

$20.30

52 Week High

$3.35

52 Week Low

HEALTHCARE

Sector

CTNM Chart

Recent Chart
Price Action

CTNM Technicals

Tags:

CTNM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue $258K
Costof Goods And Services Sold $258K
Operating Income -$51M
Selling General And Administrative $12M
Research And Development $38M
Operating Expenses $51M
Investment Income Net -
Net Interest Income $8.9M
Interest Income $8.9M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $258K
Income Before Tax -$42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$42M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$42M
Net Income -$42M

Revenue & Profitability

Earnings Performance

CTNM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $213M
Total Current Assets $206M
Cash And Cash Equivalents At Carrying Value $22M
Cash And Short Term Investments $22M
Inventory -
Current Net Receivables -
Total Non Current Assets $6.5M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $183M
Other Current Assets $1.6M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $10M
Current Accounts Payable $1.8M
Deferred Revenue -
Current Debt -
Short Term Debt $1.5M
Total Non Current Liabilities $4.8M
Capital Lease Obligations $6.3M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $6.3M
Other Current Liabilities $6.7M
Other Non Current Liabilities -
Total Shareholder Equity $198M
Treasury Stock -
Retained Earnings -$117M
Common Stock $26K
Common Stock Shares Outstanding $19M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$33M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $258K
Capital Expenditures $514K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$70M
Cashflow From Financing $109M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$42M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue $258K
Costof Goods And Services Sold $258K
Operating Income -$51M
Selling General And Administrative $12M
Research And Development $38M
Operating Expenses $51M
Investment Income Net -
Net Interest Income $8.9M
Interest Income $8.9M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $258K
Income Before Tax -$42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$42M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$42M
Net Income -$42M

CTNM News

CTNM Profile

Contineum Therapeutics, Inc. Class A Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Contineum Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to the discovery and development of innovative oral small molecule therapies targeting significant unmet medical needs in neuroscience, inflammation, and immunology. Leveraging its advanced research capabilities, Contineum aims to address critical healthcare challenges by delivering effective treatments that enhance patient outcomes. With a robust pipeline and a commitment to scientific excellence, the company is strategically positioned for growth in the biopharmaceutical industry.

ATCH
+87.36%
$1.62
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
INTC
+25.22%
$31.18
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
DVLT
+31.33%
$0.45
NFE
+8.00%
$2.16
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
LYFT
+13.12%
$22.84
SOUN
+2.92%
$15.12
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
RGTI
+9.94%
$21.99
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
JOBY
-1.59%
$14.16
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
RR
+2.84%
$3.98
WBD
-1.42%
$17.98
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AMD
-0.81%
$159.16
QS
+1.08%
$10.26
MULN
-6.96%
$0.06
WULF
+3.74%
$11.35
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
ETHD
-1.52%
$3.22
TLRY
-2.45%
$1.19
NOK
+1.95%
$4.70
QUBT
+4.97%
$17.71
VALE
-0.27%
$10.88
SRM
+53.27%
$10.30
IREN
+3.97%
$37.90
CIFR
+7.55%
$12.38
RZLV
-3.26%
$7.11
RIG
-2.01%
$3.40
CWD
+20.62%
$7.66
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
JD
+1.52%
$35.24
PLUG
+0.03%
$2.00
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MRVL
+3.07%
$70.98
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+1.52%
$17.54
ORCL
-1.70%
$301.41
JBLU
0.00%
$5.07
ROIV
+7.75%
$15.28
ETWO
0.00%
$3.30
T
+0.71%
$29.54
PEB
+2.07%
$11.80
WMT
+0.82%
$104.27
HPE
+1.22%
$24.73
PR
+1.26%
$13.56
NBIS
+5.19%
$94.08
APLD
+1.90%
$19.82
CRWV
+1.77%
$120.86
PDD
+4.49%
$134.86
NVDA
+2.74%
$174.96
KDP
+1.11%
$27.26
AFMD
-34.94%
$0.18
YAAS
-4.19%
$0.06
ATCH
+87.36%
$1.62
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
INTC
+25.22%
$31.18
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
DVLT
+31.33%
$0.45
NFE
+8.00%
$2.16
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
LYFT
+13.12%
$22.84
SOUN
+2.92%
$15.12
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
RGTI
+9.94%
$21.99
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
JOBY
-1.59%
$14.16
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
RR
+2.84%
$3.98
WBD
-1.42%
$17.98
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AMD
-0.81%
$159.16
QS
+1.08%
$10.26
MULN
-6.96%
$0.06
WULF
+3.74%
$11.35
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
ETHD
-1.52%
$3.22
TLRY
-2.45%
$1.19
NOK
+1.95%
$4.70
QUBT
+4.97%
$17.71
VALE
-0.27%
$10.88
SRM
+53.27%
$10.30
IREN
+3.97%
$37.90
CIFR
+7.55%
$12.38
RZLV
-3.26%
$7.11
RIG
-2.01%
$3.40
CWD
+20.62%
$7.66
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
JD
+1.52%
$35.24
PLUG
+0.03%
$2.00
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MRVL
+3.07%
$70.98
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+1.52%
$17.54
ORCL
-1.70%
$301.41
JBLU
0.00%
$5.07
ROIV
+7.75%
$15.28
ETWO
0.00%
$3.30
T
+0.71%
$29.54
PEB
+2.07%
$11.80
WMT
+0.82%
$104.27
HPE
+1.22%
$24.73
PR
+1.26%
$13.56
NBIS
+5.19%
$94.08
APLD
+1.90%
$19.82
CRWV
+1.77%
$120.86
PDD
+4.49%
$134.86
NVDA
+2.74%
$174.96
KDP
+1.11%
$27.26
AFMD
-34.94%
$0.18
YAAS
-4.19%
$0.06
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.